What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
His primary areas of investigation include Internal medicine, Diabetes mellitus, Diabetic nephropathy, Endocrinology and Albuminuria.
His Internal medicine research includes themes of Gastroenterology and Nephropathy.
Peter Rossing has researched Diabetes mellitus in several fields, including Risk factor, Kidney disease and Cardiology.
His biological study deals with issues like Diabetic retinopathy, which deal with fields such as Pediatrics and Case-control study.
In his study, which falls under the umbrella issue of Endocrinology, Clinical trial and Good clinical practice is strongly linked to Randomized controlled trial.
The Albuminuria study which covers Urology that intersects with Spironolactone and Cohort.
His most cited work include:
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (1461 citations)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
- Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis (667 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Diabetes mellitus, Albuminuria, Endocrinology and Type 2 diabetes are his primary areas of study.
His research in Internal medicine intersects with topics in Type 1 diabetes and Cardiology.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Surgery, Kidney disease, Gastroenterology, Blood pressure and Hazard ratio.
His Albuminuria research incorporates themes from Randomized controlled trial, Aliskiren and Confidence interval.
The Type 2 diabetes study combines topics in areas such as Placebo, Disease, Prospective cohort study and Type 2 Diabetes Mellitus.
His research investigates the connection with Diabetic nephropathy and areas like Urinary system which intersect with concerns in Biomarker.
He most often published in these fields:
- Internal medicine (141.90%)
- Diabetes mellitus (106.37%)
- Albuminuria (71.17%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (141.90%)
- Diabetes mellitus (106.37%)
- Type 2 diabetes (65.77%)
In recent papers he was focusing on the following fields of study:
Peter Rossing mainly investigates Internal medicine, Diabetes mellitus, Type 2 diabetes, Kidney disease and Renal function.
His Internal medicine study integrates concerns from other disciplines, such as Type 1 diabetes and Cardiology.
His Diabetes mellitus study improves the overall literature in Endocrinology.
His Type 2 diabetes study combines topics in areas such as Creatinine, Microalbuminuria and Cohort.
The study incorporates disciplines such as Kidney, Mineralocorticoid receptor, Dapagliflozin and Intensive care medicine in addition to Kidney disease.
The concepts of his Renal function study are interwoven with issues in Placebo, Blood pressure, Atrial fibrillation and Urology.
Between 2019 and 2021, his most popular works were:
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (639 citations)
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (639 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
His primary scientific interests are in Kidney disease, Diabetes mellitus, Internal medicine, Type 2 diabetes and Renal function.
His Kidney disease research integrates issues from Guideline and Disease.
His primary area of study in Diabetes mellitus is in the field of Type 1 diabetes.
His study focuses on the intersection of Internal medicine and fields such as Dapagliflozin with connections in the field of Diabetic nephropathy.
His Type 2 diabetes research incorporates elements of Adipose tissue, Albuminuria, Mineralocorticoid receptor and Type 2 Diabetes Mellitus.
His Renal function study is related to the wider topic of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
